CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,774,000 | -18.0% | 146,637 | -4.2% | 0.05% | -5.8% |
| Q3 2019 | $2,164,000 | +30.0% | 153,081 | +8.0% | 0.05% | +44.4% |
| Q1 2019 | $1,665,000 | +109.4% | 141,792 | +138.4% | 0.04% | +71.4% |
| Q4 2018 | $795,000 | -85.6% | 59,471 | -79.4% | 0.02% | -80.2% |
| Q3 2017 | $5,515,000 | +15.2% | 289,058 | -28.7% | 0.11% | +11.6% |
| Q2 2017 | $4,787,000 | +84.0% | 405,694 | +71.0% | 0.10% | +50.8% |
| Q1 2017 | $2,601,000 | -2.5% | 237,317 | -35.4% | 0.06% | -33.7% |
| Q4 2016 | $2,669,000 | +66.6% | 367,634 | +49.2% | 0.10% | +93.9% |
| Q3 2016 | $1,602,000 | +201.7% | 246,467 | +153.3% | 0.05% | +188.2% |
| Q2 2016 | $531,000 | +8.1% | 97,291 | -7.2% | 0.02% | +21.4% |
| Q1 2016 | $491,000 | +16.4% | 104,895 | +27.8% | 0.01% | +40.0% |
| Q4 2015 | $422,000 | +57.5% | 82,085 | +15.0% | 0.01% | +25.0% |
| Q3 2015 | $268,000 | -46.8% | 71,406 | -14.9% | 0.01% | -42.9% |
| Q2 2015 | $504,000 | +600.0% | 83,865 | +101.8% | 0.01% | +600.0% |
| Q2 2013 | $72,000 | – | 41,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |